(Q55475937)

12 July 2018

title

Human astrocytomas co-expressing Fas and Fas ligand also produce TGFbeta2 and Bcl-2. (English)

1 reference

12 July 2018

author name string

B Frankel

series ordinal

1

1 reference

12 July 2018

S L Longo

series ordinal

2

1 reference

12 July 2018

T C Ryken

series ordinal

3

1 reference

12 July 2018

publication date

1 January 1999

1 reference

12 July 2018

Journal of Neuro-Oncology

published in

1 reference

12 July 2018

volume

44

1 reference

12 July 2018

issue

3

1 reference

12 July 2018

page(s)

205-212

1 reference

12 July 2018

https://scigraph.springernature.com/pub.10.1023/a:1006311231189

exact match

0 references

cites work

Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege

1 reference

12 December 2020

BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death

1 reference

12 December 2020

Activated B cells express functional Fas ligand

1 reference

12 December 2020

Apoptosis and cell proliferation in human neuroepithelial tumors.

1 reference

12 December 2020

Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells.

1 reference

12 December 2020

Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation

1 reference

12 December 2020

Fas ligand expression in glioblastoma cell lines and primary astrocytic brain tumors.

1 reference

12 December 2020

Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?

1 reference

12 December 2020

Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes

1 reference

12 December 2020

Immunotherapy of malignant gliomas

1 reference

12 December 2020

The TGF-beta family of growth and differentiation factors.

1 reference

12 December 2020

Fas/APO-1 gene transfer for human malignant glioma.

1 reference

12 December 2020

Expression of bcl-2 in reactive and neoplastic astrocytes: lack of correlation with presence or degree of malignancy.

1 reference

12 December 2020

The cytocidal activity of OK-432-activated mononuclear cells against human glioma cells is partly mediated through the Fas ligand/Fas system

1 reference

12 December 2020

Expression of Fas/APO-1 during the progression of astrocytomas.

1 reference

12 December 2020

Immunohistological study of mononuclear cell infiltrate in malignant gliomas.

1 reference

12 December 2020

Apoptosis in cerebral astrocytic tumours and its relationship to expression of the bcl-2 and p53 proteins.

1 reference

12 December 2020

Enhanced expression of transforming growth factor-beta and its type-I and type-II receptors in human glioblastoma.

1 reference

12 December 2020

Preferential expression of Fas/APO1 (CD95) and apoptotic cell death in perinecrotic cells of glioblastoma multiforme.

1 reference

12 December 2020

Effects of transforming growth factor beta on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness

1 reference

12 December 2020

The glioblastoma-derived T-cell suppressor factor/transforming growth factor beta 2 inhibits the generation of lymphokine-activated killer (LAK) cells.

1 reference

12 December 2020

Elevated soluble Fas (sFas) levels in nonhematopoietic human malignancy

1 reference

12 December 2020

The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis

1 reference

12 December 2020

Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity

1 reference

12 December 2020

Involvement of the bcl-2 gene in human follicular lymphoma

1 reference

12 December 2020

Effect of the expression of transforming growth factor-beta 2 in primary human glioblastomas on immunosuppression and loss of immune surveillance

1 reference

12 December 2020

Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family

1 reference

12 December 2020

Immunosuppression and transforming growth factor-beta in glioblastoma. Preferential production of transforming growth factor-beta 2.

1 reference

12 December 2020

Expression of the functional soluble form of human fas ligand in activated lymphocytes.

1 reference

12 December 2020

Fas-mediated cytotoxicity by freshly isolated natural killer cells

1 reference

12 December 2020

Fas ligand and immune evasion

1 reference

12 December 2020

bcl-2 protein expression in astrocytomas in relation to patient survival and p53 gene status.

1 reference

12 December 2020

bcl-2 protein expression in tumors of the central nervous system

1 reference

12 December 2020

Transforming growth factor-beta 2 down-regulates HLA-DR antigen expression on human malignant glioma cells.

1 reference

12 December 2020

Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines

1 reference

12 December 2020

Co-expression of Fas and Fas ligand in malignant glial tumors and cell lines.

1 reference

12 December 2020

Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule

1 reference

12 December 2020

Inhibition of cytokine production by cyclosporin A and transforming growth factor beta

1 reference

12 December 2020

Role of Fas ligand (CD95L) in immune escape: the tumor cell strikes back

1 reference

12 December 2020

Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth

1 reference

12 December 2020

Immunohistochemical analysis of Bcl-2, Bcl-X, Mcl-1, and Bax in tumors of central and peripheral nervous system origin

1 reference

12 December 2020

Involvement of an ICE-like protease in Fas-mediated apoptosis

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1006311231189

1 reference

12 July 2018

Dimensions Publication ID

0 references

1 reference

12 July 2018